Moreover, in our study, pwMS included into the depleting/sequestering-out subgroup showed a higher percentage of IFNγ-IL2-TNFα+ T-cells at both time-points, compared to the enriching-in subgroup and HD in which a more heterogeneous cytokine profile was observed. The gene discussed is IFNG; the disease is Huntington disease.